News

Posted: 2018-10-23

Today, Prostate Cancer Canada and the Movember Foundation announced $4 million for three leading Canadian researchers on projects surrounding the use of biological markers in the prediction of how well prostate cancer will respond to treatment.

Posted: 2018-09-17

Dr. Yuzhuo Wang was inducted as a Fellow of the Canadian Academy of Health Sciences. He received the honour in a presentation by Dr. Linda Rabeneck, President of the CAHS in a ceremony held in Vancouver on September 13 at the Marriott Pinnacle Downtown Hotel, Vancouver, BC.  You can view the full CAHS annoucment here; the entry for Dr. Wang is:

Dr. Zoubeidi
Posted: 2018-09-12

Each year, the UBC Faculty of Medicine recognizes faculty and staff members for excellence in teaching, research, administration, innovation and public service. This year, Dr Zoubeidi was awarded a UBC Faculty of Medicine Distinguished Achievement Award for Excellence in Basic Science Research, in recognition of meritorious performance.

Dr. Gleave and Her Excellency the Right Honourable Julie Payette: Photo copyright copyright the Office of the Secretary to the Governor General
Posted: 2018-09-06

Her Excellency the Right Honourable Julie Payette, Governor General of Canada, invested Dr. Martin Gleave as a Member of the Order of Canada on Thursday, September 6, 2018, at Rideau Hall.  Dr. Gleave's appointment was reported on January 6 by VCHRI News and re-posted on VPC News on Jan 8.

Dr. Gleave
Posted: 2018-07-26

Dr Martin Gleave is the recipient of the fifth annual Dr Chew Wei Memorial Prize in Cancer Research for his work to improve outcomes from prostate cancer, which has spanned surgery, molecular manipulation in the search for new treatments, and managing the challenge of taking lab discoveries to market.  The UBC Faculty of Medicine bestows this award  annually to a Canadian physician or scientist who makes outstanding co

Posted: 2018-07-10

Drs. Zoubeidi, Black and So are PIs on three CIHR Project Grants that were funded in the March 2018 competition. The funded projects are:

Dr. Amina Zoubeidi: Hormone therapy induces reprogramming to drive aggressive prostate cancer ($669,376 over 5 years)
- Ranked 1st of 39 projects in the Cancer Biology & Therapeutics 2 Committee's review panel

Drs. Peter Black & Purang Abolmaesumi: Multi-centre Temporal Ultrasound Image Analysis for Prostate Cancer Diagnosis ($1,158,976 over 5 years)

Posted: 2018-06-12

See original press releases at VCH and BC Cancer websites.

2018 Rising Star Awardees
Posted: 2018-05-29

Vancouver Coastal Health Research Institute (VCHRI) supports tomorrow’s research leaders with the Top Graduating Doctoral Student Awards and the Rising Star Awards. These awards recognize outstanding contributions by VCHRI research trainees to research excellence, service as role models, and other contributions to the VCH research community.

Posted: 2018-05-17

The Vancouver Sun is running a five-part series on prostate cancer, written by Larry Pynn.  Links will be added as stories are published.

Part 1: Shock and choices after the diagnosis
1 in 7 Canadian men get prostate cancer, and I am among them

Dr. Peter Black
Posted: 2018-05-09

Dr Peter Black has been awarded an MSFHR Health Professional-Investigator award in partnership with Vancouver Coastal Health Research Institute and VGH & UBC Hospital Foundation.  The project, "Unraveling disparate roles of Notch-1 and Notch-2 signaling in bladder cancer" will further his ongoing work on the Notch signaling pathway in bladder cancer. Loss of the cell surface receptor Notch-1 drives growth of some bladder cancers, while increased Notch-2 activity drives other bladder cancers.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Employment

Work at the Vancouver Prostate Centre

Monday, July 8, 2019

Dr. Flannigan to lead clinical trial for scrotal pain treatment

Monday, June 3, 2019

Benefits Seen With Apalutamide Plus ADT in Metastatic Castration-Sensitive Prostate Cancer

Dr. Chi